Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott E Counts

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Neuro-Degenerative Diseases|March 7, 2008
Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's diseaseScott E Counts, Bin He, Shaoli Che, et al.
Journal of Neuropathology and Experimental Neurology|June 20, 2006
Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairmentScott E Counts, Muhammad Nadeem, Shivanand P Lad, et al.
Current Alzheimer Research|August 14, 2018
Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's DiseaseIrving E Vega, Andrew Umstead, Cassandra M Wygant, et al.
Neuropharmacology|January 22, 2014
Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairmentScott E Counts, Melissa J Alldred, Shaoli Che, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Human microRNA-153-3p targets specific neuronal genes and is associated with the risk of Alzheimer's diseaseRuizhi Wang, Bryan Maloney, Kwangsik Nho, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 15, 2016
Biomarkers for the Early Detection and Progression of Alzheimer's DiseaseScott E Counts, Milos D Ikonomovic, Natosha Mercado, et al.
Plos One|May 15, 2025
Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot studyMichael R Lawrence, Judith E Arnetz, Scott E Counts, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
MicroRNA-181 influences Alzheimer's risk by regulating neprilysin and microtubule-associated tau pathways, offering a novel targetRuizhi Wang, Bryan Maloney, Kwangsik Nho, et al.
Journal of Alzheimer'S Disease : JAD|May 21, 2017
Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of HealthIrving E Vega, Laura Y Cabrera, Cassandra M Wygant, et al.
Neuro-Degenerative Diseases|February 8, 2012
Hippocampal drebrin loss in mild cognitive impairmentScott E Counts, Bin He, Muhammad Nadeem, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Neuro-Degenerative Diseases|March 7, 2008
Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's diseaseScott E Counts, Bin He, Shaoli Che, et al.
Journal of Neuropathology and Experimental Neurology|June 20, 2006
Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairmentScott E Counts, Muhammad Nadeem, Shivanand P Lad, et al.
Current Alzheimer Research|August 14, 2018
Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's DiseaseIrving E Vega, Andrew Umstead, Cassandra M Wygant, et al.
Neuropharmacology|January 22, 2014
Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairmentScott E Counts, Melissa J Alldred, Shaoli Che, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Human microRNA-153-3p targets specific neuronal genes and is associated with the risk of Alzheimer's diseaseRuizhi Wang, Bryan Maloney, Kwangsik Nho, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 15, 2016
Biomarkers for the Early Detection and Progression of Alzheimer's DiseaseScott E Counts, Milos D Ikonomovic, Natosha Mercado, et al.
Plos One|May 15, 2025
Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot studyMichael R Lawrence, Judith E Arnetz, Scott E Counts, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
MicroRNA-181 influences Alzheimer's risk by regulating neprilysin and microtubule-associated tau pathways, offering a novel targetRuizhi Wang, Bryan Maloney, Kwangsik Nho, et al.
Journal of Alzheimer'S Disease : JAD|May 21, 2017
Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of HealthIrving E Vega, Laura Y Cabrera, Cassandra M Wygant, et al.
Neuro-Degenerative Diseases|February 8, 2012
Hippocampal drebrin loss in mild cognitive impairmentScott E Counts, Bin He, Muhammad Nadeem, et al.
Pageof 10